- Home
- ABVC vs DUO Comparison
ABVC vs DUO Comparison
Compare ABVC & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- DUO
- Stock Information
- Founded
- ABVC 2015
- DUO 2011
- Country
- ABVC United States
- DUO China
- Employees
- ABVC N/A
- DUO N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- DUO Real Estate
- Sector
- ABVC Health Care
- DUO Finance
- Exchange
- ABVC Nasdaq
- DUO Nasdaq
- Market Cap
- ABVC 16.7M
- DUO 17.1M
- IPO Year
- ABVC N/A
- DUO 2019
- Fundamental
- Price
- ABVC $0.98
- DUO $0.25
- Analyst Decision
- ABVC
- DUO
- Analyst Count
- ABVC 0
- DUO 0
- Target Price
- ABVC N/A
- DUO N/A
- AVG Volume (30 Days)
- ABVC 655.9K
- DUO 3.9M
- Earning Date
- ABVC 04-15-2025
- DUO 05-02-2025
- Dividend Yield
- ABVC N/A
- DUO N/A
- EPS Growth
- ABVC N/A
- DUO N/A
- EPS
- ABVC N/A
- DUO 0.47
- Revenue
- ABVC $509,588.00
- DUO $46,458,330.00
- Revenue This Year
- ABVC $735.18
- DUO N/A
- Revenue Next Year
- ABVC N/A
- DUO N/A
- P/E Ratio
- ABVC N/A
- DUO $0.53
- Revenue Growth
- ABVC 234.31
- DUO 19.00
- 52 Week Low
- ABVC $0.40
- DUO $0.20
- 52 Week High
- ABVC $1.73
- DUO $4.67
- Technical
- Relative Strength Index (RSI)
- ABVC 56.38
- DUO 40.54
- Support Level
- ABVC $0.81
- DUO $0.21
- Resistance Level
- ABVC $1.00
- DUO $0.28
- Average True Range (ATR)
- ABVC 0.16
- DUO 0.03
- MACD
- ABVC -0.01
- DUO 0.01
- Stochastic Oscillator
- ABVC 39.92
- DUO 62.62
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.